From April 1, 2024 to June 30, 2024, the company has repurchased 373,200 shares, representing 0.35% for CNY 10.54 million. With this, the company has completed the repurchase of 373,200 shares, representing 0.35% for CNY 10.54 million under the buyback announced on March 14, 2024.
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd
Equities
002864
CNE1000032C9
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
25.92 CNY | +0.82% |
|
+2.73% | -32.66% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-32.66% | 37Cr | |
+55.35% | 85TCr | |
+31.64% | 63TCr | |
-0.10% | 36TCr | |
+15.47% | 32TCr | |
+13.10% | 30TCr | |
+15.51% | 24TCr | |
+16.72% | 23TCr | |
+16.54% | 18TCr | |
+4.31% | 17TCr |
- Stock Market
- Equities
- 002864 Stock
- News Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd
- Tranche Update on Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd's Equity Buyback Plan announced on March 14, 2024.